相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cost Effectiveness of Whole Population BRCA Genetic Screening for Cancer Prevention in Israel
Nadav Michaan et al.
CANCER PREVENTION RESEARCH (2021)
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Uptake and timing of risk-reducing salpingo-oophorectomy among patients with BRCA1 and BRCA2 mutations
Maria J. Smith et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)
Future Screening Prospects for Ovarian Cancer
Diana Zilovic et al.
CANCERS (2021)
Population or family history based BRCA gene tests of breast cancer? A systematic review of economic evaluations
Zahra Meshkani et al.
HEREDITARY CANCER IN CLINICAL PRACTICE (2021)
Cascading After Peridiagnostic Cancer Genetic Testing: An Alternative to Population-Based Screening
Kenneth Offit et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer
Tal Hadar et al.
JAMA ONCOLOGY (2020)
Economic Evaluation of Population-BasedBRCA1/BRCA2Mutation Testing across Multiple Countries and Health Systems
Ranjit Manchanda et al.
CANCERS (2020)
Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis
Lei Zhang et al.
GENETICS IN MEDICINE (2019)
International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation
Kelly Metcalfe et al.
BRITISH JOURNAL OF CANCER (2019)
Cost-effectiveness of population genomic screening Response
Paul Lacaze et al.
GENETICS IN MEDICINE (2019)
Population frequencies of pathogenic alleles of BRCA1 and BRCA2: analysis of 173 Danish breast cancer pedigrees using the BOADICEA model
Thorkild Terkelsen et al.
FAMILIAL CANCER (2019)
Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers A Complex Discussion
Susan M. Domchek
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Evaluation of Cancer-Based Criteria for Use in Mainstream BRCA1 and BRCA2 Genetic Testing in Patients With Breast Cancer
Zoe Kemp et al.
JAMA NETWORK OPEN (2019)
Cost effectiveness of population based BRCA1 founder mutation testing in Sephardi Jewish women
Shreeya Patel et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
Christoph Engel et al.
BMC CANCER (2018)
Familial communication and cascade testing among relatives of BRCA population screening participants
Sari Lieberman et al.
GENETICS IN MEDICINE (2018)
Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population
Ranjit Manchanda et al.
JOURNAL OF MEDICAL GENETICS (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel
Efrat Schwarz Kenan et al.
ANTICANCER RESEARCH (2018)
Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referral
Sari Lieberman et al.
GENETICS IN MEDICINE (2017)
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry
Ranjit Manchanda et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Population genetic testing for cancer susceptibility: founder mutations to genomes
William D. Foulkes et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations
Elvira D'Andrea et al.
GENETICS IN MEDICINE (2016)
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry
Eric Rosenthal et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History-Based Testing
Ranjit Manchanda et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers
Y. Laitman et al.
CLINICAL GENETICS (2014)
Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation
Amy P. M. Finch et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2
Efrat Gabai-Kapara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
Claudia Marchetti et al.
BMC WOMENS HEALTH (2014)
Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?
Jae Yeon Cheon et al.
GENOME MEDICINE (2014)
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Nasim Mavaddat et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers
Brian Drohan et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
A multidisciplinary clinic for individualizing management of patients at increased risk for breast and gynecologic cancer
Natalie J. Engel et al.
FAMILIAL CANCER (2012)
Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality
Susan M. Domchek et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Screening for Founder Mutations in BRCA1 and BRCA2 in Unselected Jewish Women
Kelly A. Metcalfe et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization
Shmuel H. Klang et al.
VALUE IN HEALTH (2010)
Screening for Breast Cancer: An Update for the US Preventive Services Task Force
Heidi D. Nelson et al.
ANNALS OF INTERNAL MEDICINE (2009)
Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: A call for dialogue
Wendy S. Rubinstein et al.
GENETICS IN MEDICINE (2009)
Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers
Timothy R. Rebbeck et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer:: A multicenter, prospective study
Noah D. Kauff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Genetic epidemiology of BRCA mutations - family history detects less than 50% of the mutation carriers
Pal Moller et al.
EUROPEAN JOURNAL OF CANCER (2007)
Limited family structure and BRCA gene mutation status in single cases of breast cancer
Jeffrey N. Weitzel et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Meta-analysis of BRCA1 and BRCA2 penetrance
Sining Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2
MC King et al.
SCIENCE (2003)
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in Israel
G Hirsh-Yechezkel et al.
GYNECOLOGIC ONCOLOGY (2003)
BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer
R Moslehi et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2000)
分享论文
